Cephalexin Powder For Suspension Suppliers & Bulk Manufacturers
Available Forms: Powder for Suspension
Available Strengths: 125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL
Reference Brands: Keflex(US & EU)
Category:
Antibiotics
Cephalexin suspension inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis. It treats respiratory, skin, and urinary infections effectively. Benefits include rapid, targeted therapy, suitability for pediatric use, oral convenience, and broad-spectrum activity, making it a reliable option for managing common bacterial infections.
Cephalexin Powder for Suspension is available in Powder for Suspension
and strengths such as 125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cephalexin Powder for Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cephalexin Powder for Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cephalexin suspension is approved in the EU and US for pediatric and adult bacterial infections, including respiratory and urinary tract infections. In the EU, brands like Keflex are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with many generics available. Both regions require comprehensive dossiers, including clinical trial results, production standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for cephalexin suspension, ensuring adherence to European and American standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing